Despite all the challenges, regulations and roadblocks the cannabis industry faces, the vast majority of marijuana companies are actually doing well financially.

Nearly 90% of operating dispensaries and recreational marijuana stores, infused products companies and wholesale cultivators – the three pillars of the MJ trade – report that they are profitable or at least breaking even, according to the MMJ Industry. The cultivation and infused products/concentrates sectors are particularly lucrative, with 29% of wholesale growers and 27% of infused companies saying that they are “very profitable.”

Cultivators can hit profitability fairly quickly – often after the first harvest – and many find it relatively easy to stay in the black. I’m pretty sure a lot of that has to do with the swift production of what automated bud trimming machines do, Eh!

Now smaller states such as Connecticut issue a small number of grow licenses, which helps minimize the competitive playing field. That, in turn, can help prevent price drops. Keeping bud trimmers busy for sure. However, wholesale growers in some markets that have higher (or no) caps on licenses are increasingly facing competitive pressures and other challenges that could have an impact on the bottom line. Growers in these markets also have to face off against a vast number of competitors.

Need more anymore automated trimming machines?

Infused products companies also hit profitability fairly quickly. They lead all sectors of the industry, with 91% of infused products businesses reporting that they are at least break-even.

Startup costs are often much lower for infused companies vs. cultivators and retailers, making it easier to turn a profit. Profit margins in the retail side of the cannabis industry are more modest due in part to the fact that average startup costs for dispensaries and rec shops are higher than other sectors of the marijuana business. Median operational costs for retailers are also the highest in the industry, at around $600,000 annually, Ouch!

Notably, there’s a split when it comes to ancillary business. Companies that provide services to the marijuana industry and its customers are doing very well, with more than 40% reporting high profitability.

However, many ancillary products and technology firms are still finding their footing, with 26% losing some or a lot of money – the most by far of any sector. Many of these companies must shell out a lot of money to get started and face very strong competition, making the runway to profitability much longer.

Most of the businesses that aren’t yet making money are likely startups that are just getting underway, although some simply aren’t doing well. And, of course, the numbers don’t include businesses that were losing money and eventually folded. Sounds like they’ve could have used a couple of automated trimming machines if you ask me!

Michael Garay ~

GMP refers to the Good Manufacturing Practice Regulations promulgated by the US Food and Drug Administration under the authority of the Federal Food, Drug, and Cosmetic Act (See Chapter IV for food, and Chapter V, Subchapters A, B, C, D, and E for drugs and devices.) These regulations, which have the force of law, require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood take proactive steps to ensure that their products are safe, pure, and effective. GMP regulations require a quality approach to manufacturing, enabling companies to minimize or eliminate instances of contamination, mixups, and errors. This in turn, protects the consumer from purchasing a product which is not effective or even dangerous. Failure of firms to comply with GMP regulations can result in very serious consequences including recall, seizure, fines, and jail time.

GMP regulations address issues including record keeping, personnel qualifications, sanitation, cleanliness, equipment verification, process validation, and complaint handling. Most GMP requirements are very general and open-ended, allowing each manufacturer to decide individually how to best implement the necessary controls. This provides much flexibility, but also requires that the manufacturer interpret the requirements in a manner which makes sense for each individual business.

GMP is also sometimes referred to as “cGMP”. The “c” stands for “current,” reminding manufacturers that they must employ technologies and systems which are up-to-date in order to comply with the regulation.